BENKOWITZ MICHAEL (PRESIDENT AND COO) sold 22.50K shares of UNITED THERAPEUTICS CORP on the open market
Open‑market sale worth $9.66M. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+14.63K
Price / share
$135.42
Trade value
$1.98M
% of position
Common Stock
Shares
−964.00
Price / share
$432.55
Trade value
$416.98K
% of position
Common Stock
Shares
−2.69K
Price / share
$433.52
Trade value
$1.16M
% of position
Common Stock
Shares
−2.92K
Price / share
$434.68
Trade value
$1.27M
% of position
Common Stock
Shares
−3.20K
Price / share
$435.52
Trade value
$1.40M
% of position
Common Stock
Shares
−2.12K
Price / share
$436.45
Trade value
$925.71K
% of position
Common Stock
Shares
−890.00
Price / share
$437.70
Trade value
$389.55K
% of position
Common Stock
Shares
−585.00
Price / share
$438.34
Trade value
$256.43K
% of position
Common Stock
Shares
−575.00
Price / share
$439.35
Trade value
$252.63K
% of position
Common Stock
Shares
−511.00
Price / share
$440.71
Trade value
$225.20K
% of position
Common Stock
Shares
−170.00
Price / share
$441.94
Trade value
$75.13K
% of position
Common Stock
Shares
+7.88K
Price / share
$146.03
Trade value
$1.15M
% of position
Common Stock
Shares
−7.88K
Price / share
$417.50
Trade value
$3.29M
% of position
Net shares
+0.00
Net value
-$6.53M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/3/2025 | M · Option Exercise | +14.63K | $135.42 | $1.98M | New position | 0.00 | 14.63K |
| Common Stock Indirect | 11/3/2025 | S · Sale | −964.00 | $432.55 | $416.98K | 6.6% | 14.63K | 13.66K |
| Common Stock Indirect | 11/3/2025 | S · Sale | −2.69K | $433.52 | $1.16M | 19.7% | 13.66K | 10.97K |
| Common Stock Indirect | 11/3/2025 | S · Sale | −2.92K | $434.68 | $1.27M | 26.6% | 10.97K | 8.06K |
| Common Stock Indirect | 11/3/2025 | S · Sale | −3.20K | $435.52 | $1.40M | 39.8% | 8.06K | 4.85K |
| Common Stock Indirect | 11/3/2025 | S · Sale | −2.12K | $436.45 | $925.71K | 43.7% | 4.85K | 2.73K |
| Common Stock Indirect | 11/3/2025 | S · Sale | −890.00 | $437.70 | $389.55K | 32.6% | 2.73K | 1.84K |
| Common Stock Indirect | 11/3/2025 | S · Sale | −585.00 | $438.34 | $256.43K | 31.8% | 1.84K | 1.26K |
| Common Stock Indirect | 11/3/2025 | S · Sale | −575.00 | $439.35 | $252.63K | 45.8% | 1.26K | 681.00 |
| Common Stock Indirect | 11/3/2025 | S · Sale | −511.00 | $440.71 | $225.20K | 75.0% | 681.00 | 170.00 |
| Common Stock Indirect | 11/3/2025 | S · Sale | −170.00 | $441.94 | $75.13K | New position | 170.00 | 0.00 |
| Common Stock Indirect | 11/3/2025 | M · Option Exercise | +7.88K | $146.03 | $1.15M | New position | 0.00 | 7.88K |
| Common Stock Indirect | 11/3/2025 | S · Sale | −7.88K | $417.50 | $3.29M | New position | 7.88K | 0.00 |
| Total | +0.00 | -$6.53M | ||||||
Stock Options
Common Stock
14.63K shares
Shares
−14.63K
Strike price
135.42
Held after
41.25K
Exercisable
—
Stock Options
Common Stock
10.50K shares
Shares
−7.88K
Strike price
146.03
Held after
10.50K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Options Indirect | Common Stock14.63K shares | 11/3/2025 | M · Option Exercise | −14.63K | 135.42 | — | 41.25K |
| Stock Options Indirect | Common Stock10.50K shares | 11/3/2025 | M · Option Exercise | −7.88K | 146.03 | — | 10.50K |
Common Stock
Direct| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.65K | Direct |
| Total | 2.65K | 2.65K direct |